A Filipino-Israeli pharmaceutical company looks to invest more than P1 billion to produce a Covid-19 oral vaccine in the country, the Philippine Economic Zone Authority (PEZA) said on Thursday. In a Viber message, PEZA Director General Charito Plaza told The Manila Times that the “estimated initial capital investment is P1.4 billion,” and said the firm targeted to establish a facility for it at the Pampanga Economic Zone. Her remarks came after Plaza told the ANC cable news channel in an interview that the firm’s officials visited the country to discuss the investment. “It’s really a big investment, because they are considering the Philippines as a manufacturing hub of these Covid-19 oral vaccines and other related medicines,” she said. They are in a hurry because the Covid-19 vaccine is the most needed in this pandemic,” she added.

Source: Manila Times March 11, 2021 16:18 UTC